Gregg Beloff - Net Worth and Insider Trading

Gregg Beloff Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gregg Beloff owns 5 companies in total, including Pandion Therapeutics Inc (PAND) , Synlogic Inc (SYBX) , and Dare Bioscience Inc (DARE) among others .

Click here to see the complete history of Gregg Beloff’s form 4 insider trades.

Insider Ownership Summary of Gregg Beloff

Ticker	Comapny	Transaction Date	Type of Owner
PAND	Pandion Therapeutics Inc	2020-07-16	See Remarks
SYBX	Synlogic Inc	2019-10-21	See Remarks
DARE	Dare Bioscience Inc	2015-05-27	Interim CFO
IMGN	Immunogen Inc	2003-06-12	Vice President and CFO
IRON	Disc Medicine Inc	2021-02-05	Chief Financial Officer

Gregg Beloff Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Gregg Beloff Ownership Network

Ownership Network List of Gregg Beloff

No Data

Ownership Network Relation of Gregg Beloff

Gregg Beloff Owned Company Details

What does Pandion Therapeutics Inc do?

Pandion Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics designed to address the unmet needs of patients suffering from autoimmune diseases. Its pipeline products are PT101, PT627, PT001, and others. The firm has combined a network-based conceptualization of the immune system in advanced protein engineering to develop TALON (Therapeutic Autoimmune reguLatOry proteiN) drug design and discovery platform.

Who are the key executives at Pandion Therapeutics Inc?

Gregg Beloff is the See Remarks of Pandion Therapeutics Inc. Other key executives at Pandion Therapeutics Inc include 10 percent owner Mva Investors, Llc , director & 10 percent owner Mitchell Mutz , and 10 percent owner Polaris Partners VIII, L.P. .

Pandion Therapeutics Inc (PAND) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Pandion Therapeutics Inc (PAND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pandion Therapeutics Inc (PAND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Pandion Therapeutics Inc (PAND)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pandion Therapeutics Inc Insider Transactions

20/Page

Total 0

Ticker	Insider	Position	Date	Buy/Sell	Shares	Shares Owned	Trade Price($)	Trade Percentage(%)	Cost($1000)	Price change since trade(%)	Share ownership details	Filing Date

20/Page

Total 0

What does Synlogic Inc do?

Synlogic Inc is a biopharmaceutical company focused on the discovery and development of Synthetic Biotic medicines which are designed to metabolize a toxic substance, compensate for missing or damaged metabolic pathways, or deliver combinations of therapeutic factors. Synthetic Biotic medicines are generated from the company's proprietary drug discovery and development platform, using Synthetic Biology and leveraging a reproducible, modular approach to develop beneficial microbes that perform or deliver critical therapeutic functions. Its key product candidate is SYNB1618, an oral therapy intended for the treatment of PKU, a rare metabolic disease in which an amino acid known as phenylalanine accumulates in the body as a result of genetic defects.

Who are the key executives at Synlogic Inc?

Gregg Beloff is the See Remarks of Synlogic Inc. Other key executives at Synlogic Inc include Chief Financial Officer Michael Vangsted Jensen , Chief Operating Officer Antoine Awad , and Chief Medical Officer Richard J. Riese .

Synlogic Inc (SYBX) Insider Trades Summary

Over the past 18 months, Gregg Beloff made no insider transaction in Synlogic Inc (SYBX). Other recent insider transactions involving Synlogic Inc (SYBX) include a net purchase of 9,500 shares made by Michael Vangsted Jensen , a net sale of 8,894 shares made by Aoife Brennan , and a net sale of 2,650 shares made by Antoine Awad .

In summary, during the past 3 months, insiders sold 0 shares of Synlogic Inc (SYBX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,544 shares of Synlogic Inc (SYBX) were sold and 9,500 shares were bought by its insiders, resulting in a net sale of 2,044 shares.

Synlogic Inc (SYBX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Synlogic Inc Insider Transactions

20/Page

Total 0

Ticker	Insider	Position	Date	Buy/Sell	Shares	Shares Owned	Trade Price($)	Trade Percentage(%)	Cost($1000)	Price change since trade(%)	Share ownership details	Filing Date

20/Page

Total 0

What does Dare Bioscience Inc do?

Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, primarily in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream.

Who are the key executives at Dare Bioscience Inc?

Gregg Beloff is the Interim CFO of Dare Bioscience Inc. Other key executives at Dare Bioscience Inc include director & Chef Executive Officer Sabrina Martucci Johnson , Chief Strategy Officer John A Fair , and Chief Financial Officer Lisa Walters-hoffert .

Dare Bioscience Inc (DARE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Dare Bioscience Inc (DARE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dare Bioscience Inc (DARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dare Bioscience Inc (DARE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Dare Bioscience Inc Insider Transactions

20/Page

Total 0

Ticker	Insider	Position	Date	Buy/Sell	Shares	Shares Owned	Trade Price($)	Trade Percentage(%)	Cost($1000)	Price change since trade(%)	Share ownership details	Filing Date

20/Page

Total 0

What does Immunogen Inc do?

Immunogen Inc is a clinical-stage biotechnology company from the United States. Its focus is antibody-drug conjugate, or ADC, technology, which uses an antibody that fixes on a target (its antigen) found on tumor cells to deliver a specific cancer-killing agent.

Who are the key executives at Immunogen Inc?

Gregg Beloff is the Vice President and CFO of Immunogen Inc. Other key executives at Immunogen Inc include EVP R&D & MEDICAL AFFAIRS Michael Vasconcelles , SVP & CHIEF LEGAL OFFICER Daniel Char , and SVP & Chief Commercial Officer Kristen Harrington-smith .

Immunogen Inc (IMGN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Immunogen Inc (IMGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunogen Inc (IMGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Immunogen Inc (IMGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Immunogen Inc Insider Transactions

20/Page

Total 0

Ticker	Insider	Position	Date	Buy/Sell	Shares	Shares Owned	Trade Price($)	Trade Percentage(%)	Cost($1000)	Price change since trade(%)	Share ownership details	Filing Date

20/Page

Total 0

What does Disc Medicine Inc do?

Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of innovative therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The firm's pipeline includes investigational product candidates that affect heme biosynthesis and iron metabolism.

Who are the key executives at Disc Medicine Inc?

Gregg Beloff is the Chief Financial Officer of Disc Medicine Inc. Other key executives at Disc Medicine Inc include 10 percent owner Access Industries Holdings Llc , Chief Innovation Officer Brian Richard Macdonald , and Chief Medical Officer William Jacob Savage .

Disc Medicine Inc (IRON) Insider Trades Summary

Over the past 18 months, Gregg Beloff made no insider transaction in Disc Medicine Inc (IRON). Other recent insider transactions involving Disc Medicine Inc (IRON) include a net purchase of 932,500 shares made by Braden Michael Leonard , a net purchase of 434,783 shares made by Ai Dmi Llc , and a net purchase of 108,696 shares made by Orbimed Advisors Llc .

In summary, during the past 3 months, insiders sold 0 shares of Disc Medicine Inc (IRON) in total and bought 652,175 shares, with a net purchase of 652,175 shares. During the past 18 months, 22,500 shares of Disc Medicine Inc (IRON) were sold and 1,607,175 shares were bought by its insiders, resulting in a net purchase of 1,584,675 shares.

Disc Medicine Inc (IRON)'s detailed insider trading history can be found in Insider Trading Tracker table.

Disc Medicine Inc Insider Transactions

20/Page

Total 0

Ticker	Insider	Position	Date	Buy/Sell	Shares	Shares Owned	Trade Price($)	Trade Percentage(%)	Cost($1000)	Price change since trade(%)	Share ownership details	Filing Date

20/Page

Total 0

Gregg Beloff Mailing Address

Above is the net worth, insider trading, and ownership report for Gregg Beloff. You might contact Gregg Beloff via mailing address: C/o Cerulean Pharma Inc., 840 Memorial Drive, Cambridge Ma 02139.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF ADV Part 2A ADV Part 2B ADV Part 3 Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.